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Summary: Signaling through the Notch1 receptor is
essential for the control of numerous developmental
processes during embryonic life as well as in adult tis-
sue homeostasis and disease. Since the outcome of
Notch1 signaling is highly context-dependent, and its
precise physiological and pathological role in many
organs is unclear, it is of great interest to localize and
identify the cells that receive active Notch1 signals in
vivo. Here, we report the generation and characteriza-
tion of a BAC-transgenic mouse line, N1-Gal4VP16, that
when crossed to a Gal4-responsive reporter mouse line
allowed the identification of cells undergoing active
Notch1 signaling in vivo. Analysis of embryonic and
adult N1-Gal4VP16 mice demonstrated that the activa-
tion pattern of the transgene coincides with previously
observed activation patterns of the endogenous Notch1
receptor. Thus, this novel reporter mouse line provides
a unique tool to specifically investigate the spatial and
temporal aspects of Notch1 signaling in vivo. genesis
50:700–710, 2012. VC 2012 Wiley Periodicals, Inc.
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The Notch cascade regulates many cellular differentia-
tion events through cell-to-cell communication in a con-
text- and dose-dependent manner during embryonic
and postnatal development. In addition, dysfunctional
Notch signaling results in a large variety of developmen-
tal defects as well as adult pathologies including cancer
(reviewed in Artavanis-Tsakonas and Muskavitch,
2010). The Notch genes (Notch1–Notch4 in mammals)
encode single transmembrane cell surface receptors,
which are bound by the Delta and Jagged family mem-
bers of ligands on neighboring cells. Notch signaling is
initiated by receptor–ligand interaction that elicits two
consecutive proteolytic cleavages, S2 (Mumm et al.,
2000) and S3 (Schroeter et al., 1998), mediated by the
metalloproteases of the ADAM family (Brou et al., 2000)
and a g-sectreatese complex (De Strooper et al., 1999),
respectively. The last cleavage liberates the intracellular
domain of Notch (NIC), which translocates to the nu-
cleus (Struhl and Adachi, 1998). Once in the nucleus,
NIC associates with the DNA binding protein CSL/
RBPJj (Fortini and Artavanis-Tsakonas, 1994; Jarriault
et al., 1995) thereby recruiting other coactivators and
initiates the formation of a functional transcription acti-
vation complex driving target gene expression (Kur-
ooka and Honjo, 2000; Oswald et al., 2001; Wallberg
et al., 2002; Wu et al., 2000).
The role of Notch signaling is known to be highly
context-dependent and the molecular factors that deter-
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mine the final outcome of Notch signaling in a particu-
lar cell type or tissue remain to be fully elucidated. This
gap in knowledge is in part due to the inability to iden-
tify cell populations receiving an active Notch signal in
vivo. Several reporter mice have been generated to
address this issue (Basak and Taylor, 2007; Duncan
et al., 2005; Fre et al., 2011; Imayoshi et al., 2010; Oht-
suka et al., 2006; Souilhol et al., 2006; Vooijs et al.,
2007); however, all of them have certain limitations.
Some strategies aim to visualize endogenous Notch re-
ceptor activity, in which reporter expression is driven
by promoter regions of the Notch target genes Hes1 or
Hes5 (Basak and Taylor, 2007; Fre et al., 2011; Imayoshi
et al., 2010; Ohtsuka et al., 2006), or by multimerized
RBPJj-binding sites (Duncan et al., 2005; Souilhol et al.,
2006). Nevertheless, Hes reporters can become acti-
vated by alternative signaling pathways and thus are not
restricted to Notch-specific activation. The transgenic
reporter mouse based on multimerized RBP-jj binding
sites is Notch specific, but it is unclear through which
of the four receptors the signal is initiated. Notch recep-
tor-specific reporter lines have indeed been generated
either by replacing the cytoplasmic domain of Notch1
with a cDNA coding for the cre recombinase (Vooijs
et al., 2007) or by knocking in a Cre-ERT2 gene into the
ATG of the different Notch receptors (Fre et al., 2011).
Although receptor specific, these systems do not dis-
criminate between cells that receive an active Notch
signal and cells descending from a Notch signaling pre-
cursor. The reporter systems based on expression of
Cre-ERT2 from different Notch loci reflect Notch
receptor expression but not necessarily signaling.
Here, we report the generation of an alternative re-
porter system designed to detect cells receiving an
active Notch1 signal in vivo. The strategy is based on
the generation of a chimeric Notch1 receptor, in which
NIC is replaced by GAL4-VP16 (N1-Gal4VP16). The
Notch1-specific proteolytic cleavage sites necessary for
ligand-induced activation are preserved in this chimeric
receptor (Fig. 1a). The functionality of the N1-Gal4VP16
protein was initially confirmed in a coculture assay
(Fig. 1b), indicating that mechanistically the ligand-
dependent activation of N1-Gal4VP16 is identical to
endogenous Notch1 receptor activation.
As Notch1 signaling is dose dependent, we did not
want to interfere with the endogenous Notch1 locus
through gene targeting. Therefore, to ensure that the in
vivo expression of N1-Gal4VP16 mirrored that of endog-
enous Notch1, we opted for a transgenic approach using
a bacterial artificial chromosome (BAC) spanning a
region 125 kb upstream and 30 kb downstream of the
first and last coding exon of Notch1, respectively. We
inserted the coding sequence for N1-Gal4VP16 into the
BAC at the start codon present in the first coding exon of
Notch1 via homologous recombination (Fig. 1c) (Gong
et al., 2002; Sparwasser et al., 2004). Correct targeting of
the BAC was verified by PCR and Southern blot analysis
(data not shown, and Fig. 1d). The modified BAC was
injected into the pronucleus of fertilized FVB/N zygotes
and implanted into pseudopregnant females. Six out of
114 mice obtained, which all appeared phenotypically
normal, were germline transmitters, but only 2 founder
lines expressed detectable levels of N1-Gal4VP16 mRNA
in thymocytes (data not shown).
We further characterized these two N1-Gal4VP16
founders by crossing them with a UAS-LacZ transgenic
mouse line carrying a LacZ reporter gene under the
control of a promoter containing six Gal4 binding sites
(Govindarajan et al., 2005). Consequently, in double-
transgenic (DBL-Tg) mice, ligand-specific activation of
the chimeric Notch1 receptor results in the release of
the GAL4-VP16 protein, which translocates into the
nucleus resulting in LacZ reporter activation (Fig. 1a).
Notch1 signaling is essential for the normal develop-
ment of multiple organs during embryogenesis. At em-
bryonic day (E) 13.5 we observe a widespread, but spe-
cific b-galactosidase staining in DBL-Tg embryos (Fig.
2a,c–k), but not in UAS-LacZ littermates (Fig. 2b). In the
developing central nervous system (CNS), LacZ-activity
was predominantly detected in the medulla oblongata,
the pons (Fig. 2c) and in the spinal cord (Fig. 2d). It has
been reported that segmentation of the somites
depends on active Notch1 signaling (Conlon et al.,
1995). Accordingly, N1-Gal4VP16/UAS-LacZ mice
revealed b-galactosidase expression in the clefts
between the growing somites (Fig. 2d). Proteolytic
cleavage of the N1-Gal4VP16 transgene was also
detected in the developing heart at E13.5 (Fig. 2e).
Notch1 signaling was shown to be important for digit
formation and to be expressed at the apical ectodermal
ridge (AER) from E10.5 onwards (Francis et al., 2005).
Concurrent with this report, N1-Gal4VP16 activity in
the AER was observed at E10.5 (Fig. 2f), E12.5 (Fig. 2g),
and E13.5 (Fig. 2h). Moreover, Notch1 activation is cru-
cial for the formation of the vasculature during embryo-
genesis (Krebs et al., 2000). In agreement with these
findings, we show that maturing blood vessels in double
transgenic mice at E18.5 positively stain for b-galactosi-
dase, presented by blood vessels at the surface of the
brain (Fig. 2i) and in the dermis (Fig. 2j,k). Costaining
with the endothelial cell marker CD31 and X-Gal con-
firms that N1-GALVP16 driven reporter activity was re-
stricted to endothelial cells (Fig. 2k).
Analysis of X-Gal stained adult back skin and vibrissae
established that N1-GalVp16 is continuously active in
the sebaceous glands (SG) of hair follicles (HFs) and
vibrissae (Fig. 3a–g). N1GalVp16 activity in the inner
root sheet and the differentiating cells above the line of
Auber (Au) was observed only during anagen phase of
the hair cycle (Fig. 3a,e,f). In addition, during telogen
and early anagen HFs exhibit LacZ-staining in the isth-
mus (Fig. 3c,d). Moreover, in both anagen and catagen
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FIG. 1. Generation of the N1-Gal4VP16 mouse founder lines. (a) Outline of the protein structure and the signaling pathway of the endoge-
nous Notch1 receptor (top) and the modified receptor, N1-Gal4VP16 (bottom). The Notch1 receptor is presented on the cell surface as a
heterodimer. The engagement of the Notch1 extracellular domain with its ligand triggers two consecutive proteolytic cleavages, S2 and S3,
which leads to the release of the Notch intracellular domain (NIC). In the nucleus, NIC forms a binary complex with RBPjj, which recruits
coactivators (CoA) to form the transcription-activating complex. In our model system, the NIC was replaced by the highly potent transcrip-
tion factor Gal4-VP16. The shift from Notch1 to Gal4VP16 is at Arg1752, and consequently S2 and S3 are preserved in the fusion protein.
Hence, interaction between an endogenous Notch ligand and the chimeric N1-Gal4VP16 receptor results in the proteolytic cleavage of the
receptor followed by translocation of the Gal4VP16 protein into the nucleus, where it activates the expression of a Gal4-dependent LacZ re-
porter gene. EGF, epidermal growth factor-like repeats; LNR, Lin-Notch repeats; RAM, ram domain; ANK, ankyrin repeats; TAD, transactiva-
tion domain; PEST, PEST domain. (b) Functional assessment of the N1-Gal4VP16 construct in vitro. Relative luciferase activity was detected
in HeLa cells transiently transfected with a reporter plasmid under the control of five Gal4 binding sites (pFRLuc), along with pBluescript or a
N1-Gal4VP16 expression plasmid. Twelve hours after transfection, cells were cocultured for 24 h with HeLa cells expressing the Notch
ligand Delta-like4 (DL4), with or without the g-secretase inhibitor DAPT (10 lM), as indicated. Data shown is a representative of three trans-
fection experiments normalized to the internal TK-Renilla control. Reporter activities obtained upon cotransfecting pBluescript and pFRLuc
were normalized to one, and error bars indicate SD. (c) Illustration of the strategy to generate the modified BAC integrated with the N1-
Gal4VP16 cassette into the ATG of the mouse Notch1 gene. The shuttle vector contained a targeting construct of a 6.5 kb N1-Gal4VP16
sequence flanked by a 1.1 kb 50 and 1.2 kb 30 arm of homology, respectively. The modified BAC, shown at the bottom, is a product of ho-
mologous recombination between the wt BAC and the shuttle vector. Transgenic mouse lines were established by injections of the modified
BAC into the pronuclei of fertilized FVB/N oocytes. Notch1 exon 1 and 2 are shown as light blue and blue squares, respectively, the Notch1
extracellular domain in light gray, Gal4VP16 in green, and the BGH polyA tail in white. (d) Southern-blot analysis of N1-Gal4VP16 transgenic
founder lines. Genomic DNA was digested SalI/EcoRV and hybridized with 32P-labelled PCR-products corresponding to the 30-homologous
arm or Gal4VP16 as indicated. The blot shows the N1-Gal4VP16 (12.2 kb) transgenic band for two N1-Gal4VP16 founder lines (26240 and
27075). The 5.7 kb band corresponds to the wt Notch1 alleles.
whiskers the differentiated cells, but not the basally
located stem cells in the bulge region, stained positive
for N1-GALVP16 driven b-galactosidase activity (Fig.
3f,g). The timing of hair morphogenesis and of the first
hair cycle in the DBL-Tg mice was identical to control
animals (data not shown) (Alonso and Fuchs, 2006;
FIG. 2. Active Notch1 signaling visualized through N1-Gal4VP16 activity during embryonic development. (a–k) Whole mount b-galactosi-
dase staining of transgenic embryos: (a) N1-Gal4VP16/UAS-LacZ and (b) UAS-LacZ embryos at E13.5. (c,d) Sections (500 lm) of a X-Gal
stained E13.5 DBL-Tg embryo showing high N1-Gal4VP16 activity in (c) the medulla oblongata and (d) in the spinal cord and clefts between
the forming somites (arrows). (e) N1-Gal4VP16 activity in the developing heart of an E13.5 N1-Gal4VP16/UAS-LacZ embryo. (f–h) A streak
of LacZ staining (arrows) was apparent in the AER of (f) E10.5, (g) E12.5, and (h) E13.5 N1-Gal4VP16/UAS-LacZ embryos. (i) Ventral view of
the brain from an E18.5 N1-Gal4VP16/UAS-LacZ mouse showing LacZ staining in cerebral arteries. (j) Notch1 signaling is active in the endo-
thelium of the skin at E18.5 as demonstrated by (j) X-Gal staining and (k) antibodies directed against b-galactosidase and the endothelial
cell marker CD31. Separate images of the respective fluorochrome channels are shown to the left of the merged image.
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FIG. 3. N1-Gal4VP16 activity reflects active Notch1 signaling in the hair follicle. (a–e) Cross-sections of whole mount X-Gal stained back-
skin of N1-Gal4VP16 mice at (a) p14 (anagen), (b) p18 (catagen), (c) p20 (telogen), (d, e) p24 and p26 (first postnatal anagen). (f, g) Cross-
section of whole mount X-Gal stained vibrissae in (f) anagen and (g) catagen phase. (h–j) X-Gal stained backskin 0, 3, and 10 days following
dermabrasion. (k–m) Cross-section of X-Gal stained N1-Gal4VP16/UAS-LacZ skin from (k) the snout region and (l, m) the footpad. Nuclei
are counterstained with nuclear fast red, and appear pink. Scale bars 5 100 lm or as indicated. IRS, inner root sheath; SG, sebaceous
gland; Bu, bulge; DP, dermal papilla; Ist, isthmus; Inf, infundibulum, CH, club hair, Au, line of Auber; ORS, outer root sheet.
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Paus and Foitzik, 2004). Dermabrasion studies per-
formed on DBL-Tg mice suggest that Notch1 signal-
receiving cells contribute to the regeneration of HFs
and epidermis (Fig. 3h–j). HFs from the snout area dis-
play b-galactosidase positive cells in the SG, outer root
sheet, and the bulge (Fig. 3k). Units of N1-GalVP16 ac-
tivity were also detected in the footpad (Fig. 3l), with
sporadic staining in the basal layer (Fig. 3m).
X-Gal staining of intestinal segments from DBL-Tg ani-
mals indicates that Notch1 activity is restricted to the in-
testinal crypts in the duodenum (Fig. 4a), as well as in
the jejunum and ileum (data not shown). Notch1 signal-
ing has been proposed to be active in crypt progenitors
and in Lgr51 stem cells at the bottom of the intestinal
crypt (Pellegrinet et al., 2011). Indeed, cells at the crypt
base of the DBL-Tg mice revealed b-galactosidase stain-
ing in crypt progenitors and in intestinal stem cells
wedged between the Paneth cells (Fig. 4b,c). This
notion was further confirmed upon costaining with the
Paneth cell marker lysozyme (Fig. 4e). Staining of wild
type duodenum for cleaved Notch1 using the Val1744
antibody established that the N1-GalVP16 activity is
indeed representative for Notch1 activation in the intes-
tine (Fig. 4d). In addition, LacZ-activity was observed in
the colon at the crypt base as well as in the proliferative
compartment (Fig. 4f). To further confirm the in vivo g-
secretase-dependent activation of the N1-GALVP16
fusion protein, DBL-Tg mice were treated with the g-
secretase inhibitor dibenzazepine (DBZ). The absence
of LacZ-positive cells accompanied with goblet cell
FIG. 4. N1-GalVP16 activity is restricted to the intestinal crypt. (a–c) Whole mount X-Gal stained duodenum from adult N1-Gal4VP16/
UAS-LacZ mice. (a) 4 lm paraffin section and (b, c) 6 lm frozen sections showing b-galactosidase positive cells wedged between the Pan-
eth cells (arrows) at the crypt base. (d) Immunohistological staining of wild type duodenum with the cleaved Notch1 (Val1744) antibody con-
firms that Notch1 activity is restricted to the intestinal crypt and is present in cells wedged between the Paneth cells (inset). (e) Lysozyme
staining marking the Paneth cells in a cross-section of whole mount X-Gal stained N1-Gal4VP16/UAS-LacZ duodenum. (f) Whole mount
X-Gal stained paraffin sections of N1-Gal4VP16/UAS-LacZ colon. (g, h) Whole mount X-Gal stained intestine from a DBZ-treated 21 day old
N1-Gal4VP16/UAS-LacZ mouse. (h) Goblet cells stained by a Periodic Acid Schiff (PAS) staining.
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metaplasia in the small intestine indicated a complete
block of endogenous Notch signaling as well as N1-
Gal4VP16 activity (Fig. 4g,h), which is in agreement
with previous reports (Pellegrinet et al., 2011).
Reproductive organs revealed specific LacZ-staining
in the pseudostratified columnar epithelial cells of the
epididymis wall (Fig. 5a) and in the uterine glands
(Fig. 5b). Notch1-activity was not observed in the testis
or mature spermatozoa (data not shown). In the mam-
mary gland from a lactating female, scattered luminal
epithelial cells were LacZ-positive (Fig. 5c), while no
N1-Gal4VP16-activity was observed in the mammary
glands from virgin females (data not shown).
In the adult brain, Notch1 reporter activity was
most distinct in the lateral ventricles (LV), but also
present in astrocytes (Fig. 6a,c). No LacZ-positive
cells were detected in the brain of UAS-LacZ litter-
mate control animals (Fig. 6b). Staining of wild type
brain with the anti-Val1744 antibody confirms that
endogenous Notch1 activity is mirrored by the pat-
tern of reporter activity (Fig. 6d). This is in agree-
ment with data from Carle´n et al., stating that epen-
dymal cells lining the LV wall receive active Notch1
signals (Carlen et al., 2009).
Taken together, the N1-Gal4VP16 activity observed in
our BAC-transgenic reporter mice correlates well with
the expected profile of active Notch1 signaling based
on established knowledge and antibody staining assays.
Thus, we conclude that the activation of the N1-
Gal4VP16 is consistent with the activity of the endoge-
nous Notch1 receptor. Moreover, this reporter mouse is
a powerful tool, which enables the visualization of




The N1-Gal4VP16 targeting vector was generated by
replacing the intracellular domain of the Notch1 recep-
tor with a cDNA fragment encoding for Gal4VP16. Fur-
thermore, a 1.1 kb and a 1.2 kb fragment immediately
upstream and downstream of the endogenous Notch1
ATG were amplified by PCR (688C, 30 cycles) using




CCCTTGCTCT-30), and #4 (50-TACTCCTTAATTAAGTT-
CAAACACAAGATACGAGGGGACCG-30) and a BAC clone
(RP23-412O13, CHORI BACPAC Resources Center, Oak-
land, CA) encoding the complete mouse Notch1 gene
locus as a template. The purified PCR fragments were
cloned upstream of the N1-Gal4VP16 ATG, and down-
stream of the cDNA3.1 bovine growth hormone (BGH)
polyA tail. The whole recombination cassette, N1-
Gal4VP16 including the homologous arms, was trans-
ferred to the shuttle vector pLD53.SC-AB (Gong et al.,
2002; Metcalf et al., 1996) (kindly received from Dr. Ge-
rard Eberl) and inserted into the site of the Notch1 ATG
in the wild-type BAC, via a two-step homologous recom-
bination as previously described (Gong et al., 2002;
Sparwasser et al., 2004). Briefly, the shuttle vector car-
rying the N1-Gal4VP16 recombination cassette was
electroporated into the BAC-containing bacteria
(DH10B RecA2 cells), and selected on Luria broth (LB)
agar plates containing chloramphenicol (12.5 lg/ml)
and ampicillin (50 lg/ml). Successful integration of the
shuttle vector into the BAC was confirmed by PCR
FIG. 5. Cells within reproductive organs and mammary glands display N1-Gal4VP16 activity. (a, b) Whole mount X-Gal staining of adult
N1-Gal4VP16/UAS-LacZ (a) epididymis and (b) uterus reveal b-galactosidase positive cells in the (a) pseudostratified columnar epithelial
cells of the epididymis wall and (b) the endometrial uterine glands. (c) X-Gal staining of a frozen section of a mammary gland from a N1-
Gal4VP16/UAS-LacZ-positive lactating female show interspersed N1-Gal4Vp16 activation in the luminal epithelial cells of the lobular aveoli.
Scale bars5 50 lm.
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using the following primer pairs: #5 (50-AAAGGGA-
TAAGGAAGGCATCTTGGACGC-30) and #6 (50-
AGTAGCTTGTATTCTATAGTGTCACC-30), or #7 (50-
TAGGGTGATGGTTCACGTAGTGCG-30) and #8 (50-ACA-
CAGCCAAAGTGGGAGGGGATTAAGG-30).
Colonies positive for double integration were
selected again on LB-agar plates containing chloram-
phenicol (12.5 lg/ml) and sucrose (5%). Resolved and
modified BAC clones were identified by PCR with
primer pairs listed above, and by Southern blot analysis
using a 32P-labeled probe specific for the 30 homologous
arm (for details see below). The modified BAC DNA was
purified and injected into pronuclei of fertilized FVB/N
zygotes. Offspring was typed for the presence of the
N1-Gal4VP16 transgene using the following primers
pairs: #9 (50-CTAGGTGCTCTTGCGTCACTTGGC-30) and
#10 (50-CTCCACTGAAGCCAATCTATCTGTG-30).
Founder lines typed positive for the transgene N1-
Gal4VP16 by PCR were also verified by Southern blot
analysis (see details below). Heterozygous N1-
Gal4VP16 mice were subsequently crossed with the
UAS-lacZ transgenic reporter mice, kindly provided by
Dr. P. Overbeek, Houston (Govindarajan et al., 2005).
The UAS-lacZ mice were genotyped with primers spe-
cific for the lacZ gene: #11 (50-CCCATTACGGTCAA
TCCGCCG-30) and #12 (50-GCCTCCAGTACAGCGCG
GCTG-30).
Details for individual PCR reactions will be provided
upon request. This transgenic Notch1 signaling specific
reporter mouse line will be available to the research
community upon acceptance of the manuscript.
The g-secretase inhibitor DBZ (25 lM/kg body weight
in dimethyl sulfoxide (DMSO); Calbiochem, San Diego,
CA) was injected intraperitoneally for four consecutive
days. Mice were analyzed 24 h after the last injection.
Ethics Statement
All animal work was conducted according to Swiss
national guidelines and under EPFL animal care regula-
tions. They were housed in individual cages at (23 6
1)8C with a 12 h light/dark cycle. All animals were sup-
plied with food and water ad libitum. This study has
been reviewed and approved by the Service Ve´te´rinaire
Cantonal of Etat de Vaud.
FIG. 6. N1-Gal4VP16 activity mirrors active Notch1 signaling in the brain. (a–c) X-Gal staining of 35 lm thick free floating brain sections
from (a, c) a double transgenic mouse, and (b) a UAS-LacZ positive littermate control. (c) Magnification of the left lateral ventricle (LV), stip-
pled box in (a). (d) Immunohistochemistry staining of 35 lm wild type brain free floating sections with cleaved Notch1 (Val1744) antibody
confirms high Notch1 activity in the LV.
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Southern Blot Hybridization
Southern blot hybridizations were performed follow-
ing standard procedures. Briefly, 20 lg of BAC or
genomic tail DNA were digested with SalI/EcoRV restric-
tion enzymes and resolved in an 0.8% agarose gel.
Digested DNA was transferred onto a Hybond-N1 nylon
membrane (GE Healthcare Life Sciences, Buckingham-
shire, UK) and hybridized overnight at 658C with either
a 32P-labelled PCR product corresponding to the 30-
homologous arm or a 32P-labelled 700 bp Gal4VP16
fragment amplified using the following primers: #13 (50-
GCGCATGAAGCTACTGTCTTCTA TCG-30) and #14 (50-
GCTACCCACCGTACTCGTCAA TTCC-30).
Positive labeled N1-Gal4VP16 transgenic samples
were visualized using a Phosphorimager (FLA3000;
Fujifilm).
Tissue Culture Conditions, Transfections, and
Luciferase assays
HeLa cells were cultured at 378C and 5% CO2 in Dul-
becco’s Modified Eagle’s Medium (DMEM) (high glu-
cose, GlutaMAX2-I) medium supplemented with 10%
fetal calf sreum (FCS) and 0.1 mg/ml Penicillin/Strepto-
mycin (all purchased from Gibco1, Invitrogen Corpora-
tion, Paisley, UK). HeLa cells seeded into a 12-well tissue
culture plate were transiently transfected with 2 lg of a
DL4 expression plasmid, or 1 lg pFR-Luc (Stratagene,
Offenbach, Germany) and 50 ng of prL-TK (Promega
Corporation, Madison, WI) reporter plasmids, along
with 1 lg pBluescript (Stratagene, Offenbach, Ger-
many) and the N1-Gal4VP16 expression plasmid using
the transfection reagent JetPEI2 (PolyPlus Transfection,
Illkirch, France) according to the manufacturer’s recom-
mendations. In order to induce N1-GAL4VP16 driven
activation of the reporter gene, N1-GAL4VP16 express-
ing cells were cocultured with DL4 expressing HeLa
cells in a 1:1 ratio in the presence or absence of 10 lM
DAPT (Merck & Co., New Jersey, USA). Twenty-four
hour post-coculture, cells were lysed using 250 ll of
passive lysis buffer and the luciferase assay was per-
formed with a Dual-Luciferase2 Reporter Assay System
(Promega Corporation, Madison, WI) using 20 ll of the
total protein extract. All samples were analyzed in
triplicates.
X-Gal Staining
Whole mount embryos (10.5–14.5 dpc) as well as dis-
sected whole mount organs (18.5 dpc to adult mice)
were fixed at 48C in LacZ fixative (0.2% glutaraldehyde,
5 mM EGTA (pH 7.3) and 4 mM MgCl2 in 0.1M sodium
phosphate buffer (pH 7.3)), washed three times in de-
tergent wash (2 mM MgCl2, 0.01% desoxycholate, and
0.02% NP40 in 0.1 M sodium phosphate buffer (pH
7.3)), and stained for b-galactosidase activity for 2–24 h
at 378C in detergent wash supplemented with 0.66 mg/
ml X-Gal, 3.33 mM K3Fe(CN)6, 3.33 mM K4Fe(CN)6, and
20 mM Tris–HCl (pH 7.3). Subsequently, the embryos
and organs were rinsed in 13 PBS and postfixed for 1–3
h in 4% paraformaldehyde (PFA). Embryos were photo-
graphed as whole mount, or embedded in 5% agarose in
13 phosphate buffered saline (PBS) and sectioned at
500 lm using a vibratome. For histology, whole mount
stained tissues were dehydrated, paraffin embedded,
sectioned at 4 lm, and counterstained with Nuclear
Fast Red according to standard procedures. X-Gal
stained whiskers and intestine were embedded in opti-
mal cutting temrature (OCT) tissue matrix and proc-
essed as described above. b-Galactosidase activity in the
adult brain of transgenic mice was visualized after trans-
cardial perfusion using 4% PFA. Brains were postfixed
for 1 h at 48C in 4% PFA, cryoprotected in 30% sucrose
over night, embedded in OCT, cut in 35 lm free floating
coronal sections, and stained as described above.
Immunohistochemistry
Immunofluorescent costaining for CD31 and b-galac-
tosidase were done on sections (6 lm) of fresh frozen
skin. The sections were fixed in methanol, blocked in
1% bovine serum albumine (BSA), and stained at 48C
overnight with the following primary antibodies; mono-
clonal rat anti-mouse CD31 (1:100 dilution; BD Phar-
mingen, BD biosciences, San Jose, CA) and polyclonal
goat anti-b-galactosidase (1:150 dilution; Biogenesis,
AbD Serotac, Oxon, UK). Alexa Fluor 568 goat anti-rat
IgG (dilution 1/1000; Molecular Probes, Life Technolo-
gies Corporation), and Alexa Fluor 488 donkey anti-goat
IgG (dilution 1/800; Molecular Probes, Life Technolo-
gies, Carlsbad, CA) were used as secondary antibodies,
and nuclei counterstained with DAPI. Lysozyme staining
was performed on paraffin sections of whole mount X-
Gal stained intestinal samples. Sections were dewaxed,
rehydrated, pretreated with peroxidase (5 min, 3%
H2O2), antigen retrieved (20 min at 958C in 10 mM so-
dium citrate buffer pH 6.0), and stained with a rabbit
anti-lysozyme antibody (1:500 dilution overnight at 48C;
DAKO, Glostrup, Denmark). HRP-labeled anti-rabbit
antibody was used for second stage staining and the
chromogen-substrate was detected with DAB revelation
(Sigma, St. Louis, MO). Sections from whole mount X-
Gal stained intestine DBZ-treated mice were stained
using the Periodic acid-Schiff (PAS) technique and coun-
terstained with Mayer’s Hematoxylin. Cleaved Notch1
was detected on sections of 4% PFA-fixed paraffin em-
bedded wild type intestine. Antigen retrieval was per-
formed in DIVA decloaker buffer (Biocare medical, Con-
cord, CA) and sections were incubated with a primary
rabbit polyclonal antibody raised against cleaved
Notch1 Val1744 (1:300 dilution overnight at 48C;
Abcam, Cambridge, UK). Sections were then incubated
with horseradish peroxidase (HRP) labeled polymers
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conjugated to goat anti-rabbit immunoglobulins (EnVi-
sion+ System, DAKO, Glostrup, Denmark) and the stain-
ing was visualized with DAB revelation (Sigma, St. Louis,
MO). Cleaved Notch1 in the brain was revealed on 35
lm free floating sections of wild type mice perfused
with 4% PFA. Sections were treated with 1N HCl for 30
min at 658C, quenched for 15 min at RT [3% H2O2 and
10% methanol in 0.1 M potassium phosphate buffered
saline (KPBS)] and incubated for 1 h in blocking solu-
tion (5% normal serum and 0.25% Triton-X in KPBS).
Subsequently, sections were stained with a primary anti-
body directed against cleaved Notch1 Val1744 (1:200
dilution in blocking solution overnight at RT; Abcam,
Cambridge, UK). A biotinylated goat anti-rabbit IgG sec-
ondary antibody (Vector Laboratories, Burlingame, CA)
was then applied for 1 h at RT. Antibody binding was
visualized using the Vectastain ABC kit (Vector Labora-
tories, Burlingame, CA) and DAB-revelation.
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